Oman’s healthcare system is entering a phase of continued capacity development, creating recurring demand for products used in diagnosis, treatment, surgery, infection prevention, and routine patient care. Medical consumables are closely linked to clinical activity because many products are single-use or replaced frequently, making healthcare infrastructure and procedure volumes important factors shaping procurement requirements.

The Oman healthcare consumables landscape covers hospitals, multispecialty hospitals, specialty clinics, surgical and non-surgical applications, and a broad range of product divisions. These include exam gloves, surgeons’ gloves, diagnostics consumables, anaesthesia supplies, advanced wound care, vascular access, laboratory consumables, respiratory products, infection-control supplies, urology products, and other clinical applications.

The sector is being influenced by several interconnected factors rather than a single source of demand. Healthcare infrastructure expansion, chronic disease management, preventive care, specialty treatment capacity, procurement requirements, and supply-chain considerations are collectively shaping the way consumables are purchased and used across Oman.

Healthcare Investment Supports Recurring Demand

Government commitment to healthcare development is an important structural factor. Oman has been increasing its focus on healthcare capacity, service quality, and long-term system sustainability. The National Health Policy launched in 2025 places emphasis on cross-sector collaboration and managing demographic changes and non-communicable diseases, supporting continued attention to healthcare delivery across different levels of the system.

Expansion of hospitals, specialty centres, primary-care facilities, and regional health infrastructure can increase the number of clinical procedures and patient interactions. Each additional treatment pathway can generate recurring requirements for products such as gloves, syringes, IV supplies, wound-care materials, diagnostic consumables, and infection-control products. As healthcare access becomes more geographically distributed, demand can also extend beyond major urban centres.

Chronic Diseases Strengthen Long-Term Consumption

Chronic disease management is another significant demand driver. Conditions including diabetes, hypertension, cardiovascular diseases, and cancer require ongoing monitoring, diagnosis, treatment, and follow-up. Unlike one-time healthcare episodes, chronic care creates repeated clinical interactions and therefore recurring consumption of medical supplies.

According to the Oman report, non-communicable diseases account for a substantial proportion of deaths in the country, increasing the importance of long-term healthcare management. Routine diagnostic testing, vascular access, injection-related supplies, and other disposable products can therefore remain relevant across extended treatment cycles. This creates a more stable consumption base alongside demand generated by acute procedures.

Exam Gloves Remain a Major Product Category

Exam gloves occupy a prominent position within Oman’s medical consumables landscape because they are used across hospitals, clinics, laboratories, dialysis facilities, and ambulatory healthcare settings. Their broad application means demand is not dependent on one specialty or procedure. Infection prevention practices further reinforce their importance in routine patient contact and clinical procedures.

The MarkNtel Advisors analysis identifies exam gloves as the leading division, accounting for about 13% of the sector in 2025. The report also highlights the role of public procurement systems, clinical hygiene requirements, and expanding healthcare capacity in supporting recurring glove consumption. These factors make exam gloves an important indicator of routine consumables utilization.

Disposable Products Shape Procurement Priorities

Disposable products represent another important part of Oman’s healthcare consumables ecosystem. The disposable segment accounted for approximately 65% of the sector in 2025, according to MarkNtel Advisors. Single-use supplies are widely used in surgical, dialysis, oncology, critical-care, laboratory, and infection-control environments because they support hygiene and reduce the risks associated with repeated use.

Procurement decisions increasingly require a balance between product availability, quality, regulatory compliance, clinical performance, and cost. For healthcare providers, reliable supply is particularly important for high-frequency products because shortages can affect routine clinical workflows. This makes inventory planning and supplier reliability important considerations alongside product specifications.

Advanced Wound Care Is Moving Toward Premium Products

Oman is also seeing greater attention toward differentiated wound-care products. Healthcare institutions are increasingly adopting advanced dressings and treatment systems designed to address specific clinical requirements. Products such as antimicrobial dressings, foam and alginate dressings, silicone-border wound covers, collagen-based solutions, and single-use negative pressure wound therapy kits are becoming part of more specialized wound-management approaches.

This shift reflects a broader move from basic wound-care materials toward products selected according to clinical performance and treatment protocols. The trend is particularly relevant for patients requiring prolonged wound management, including individuals affected by chronic conditions. Greater use of advanced wound-care solutions can therefore influence both product mix and procurement priorities.

Specialty Healthcare Expansion Creates New Opportunities

Expansion of specialty healthcare infrastructure is another factor shaping demand through 2032. Investments in oncology, nephrology, dialysis, advanced surgery, and referral services can increase the intensity of consumable use because these specialties often require specialized and frequently replenished clinical supplies.

Medical industrial development may also influence the supply side. The Oman report highlights initiatives involving medical and pharmaceutical manufacturing facilities, including planned production capacity for products such as medical gloves and sterile gauze. Greater local manufacturing could gradually complement imported supplies and improve supply-chain resilience for selected consumable categories.

Import Dependence Remains a Key Challenge

Despite localization initiatives, Oman continues to depend significantly on international suppliers for several medical consumables. The report notes that imported diagnostic reagents and medical test kits represented a major category of consumables imports, while other products such as syringes and sterile supplies also rely on international sourcing.

Import dependence can expose healthcare distributors and providers to freight disruptions, currency movements, global supply shortages, and procurement delays. Regulatory procedures can add another layer of complexity because suppliers must meet requirements related to product registration, quality certification, conformity assessment, and safety documentation before gaining access to the market.

Outlook Through 2032

MarkNtel Advisors estimates that Oman’s medical consumables sector will increase from USD 78.75 million in 2025 to USD 112.29 million by 2032, representing a projected CAGR of 6.6% during 2026–2032. The outlook reflects the combined influence of healthcare infrastructure development, chronic disease management, specialty-care expansion, recurring disposable-product consumption, and evolving procurement practices.

Overall, Oman’s medical consumables demand is likely to remain closely connected to the modernization of healthcare delivery. Hospitals and specialty facilities will continue generating recurring requirements, while exam gloves, disposable products, diagnostics, wound care, and other clinical supplies will shape procurement patterns. At the same time, local manufacturing initiatives and efforts to strengthen healthcare capacity may gradually influence the country’s supply structure through 2032.